Skip to main content
KANGSTEM BIOTECH CO., LTD. logo

KANGSTEM BIOTECH CO., LTD. — Investor Relations & Filings

Ticker · 217730 ISIN · KR7217730001 KO Manufacturing
Open in API
Filings indexed 414 across all filing types
Latest filing 2023-10-26 Capital/Financing Update
Country KR South Korea
Listing KO 217730

About KANGSTEM BIOTECH CO., LTD.

https://kangstem.com

KANGSTEM BIOTECH CO., LTD. is a biopharmaceutical company that researches and develops advanced stem cell therapies. The company focuses on creating treatments for rare, incurable, and autoimmune diseases, with a pipeline that includes therapeutic candidates for neurological disorders. Leveraging proprietary technologies for the isolation and mass culture of mesenchymal stem cells, Kangstem Biotech also develops and commercializes stem cell culture media and related cosmetic products. The company is dedicated to addressing unmet medical needs through the development of next-generation biopharmaceuticals.

Recent filings

Filing Released Lang Actions
유상증자최종발행가액확정
Capital/Financing Update Classification · 100% confidence The document is an official announcement from Kangstem Biotech regarding the final issuance price for a paid-in capital increase (rights offering). It details the calculation methodology, the final price per share, and the number of shares to be issued. This falls under the category of capital and financing updates, specifically related to share issuance and capital structure changes.
2023-10-26 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) filed by Kangstem Biotech. It details the correction of the final issuance price for a capital increase, including updated financial tables for the use of funds and share issuance details. This falls under the category of announcements regarding new share issues or capital changes.
2023-10-26 Korean
[발행조건확정]증권신고서(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Services Commission of South Korea. It specifically details the finalization of issuance conditions (발행조건확정) for a capital increase (유상증자). This document is a regulatory filing that provides detailed information about the offering price, number of shares, and use of proceeds, which falls under the category of capital and financing updates.
2023-10-26 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 98% confidence The document is a 'Correction Report' (정정신고) for an 'Investment Prospectus' (투자설명서) filed by Kangstem Biotech. It details changes to the final offering price (from 1,426 KRW to 1,165 KRW) and the resulting adjustments in total offering amount and fund usage plans. In the context of financial filings, a document that provides detailed terms of a securities offering, including price, usage of proceeds, and risk factors, is classified as a Prospectus. Since this is a formal regulatory filing for a capital raise, it falls under the 'Capital/Financing Update' category.
2023-10-26 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and Korea Exchange. It details the acquisition of shares in 'Kangstem Biotech' by 'Sejong Corp', crossing the 5% threshold. This type of filing is a standard regulatory requirement for major shareholders to disclose their ownership stakes and changes therein, which falls under the 'Major Shareholding Notification' category.
2023-10-20 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details changes in share ownership by major shareholders and special related parties, including acquisition methods, share counts, and percentages. This fits the 'Major Shareholding Notification' category.
2023-10-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.